The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Oncology Impact Private Investment Fund 2, L.p. since 2026.
This trader's CIK number is 2104306.
At the time of last reporting, Oncology Impact Private Investment Fund 2, L.p. was the Officer of Aktis Oncology, Inc.. (stock ticker symbol AKTS).
Also see all insider trading activities at Aktis Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | AKTS | 1,112,777 | $20,029,986 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-12 | AKTS | Buy | 1,112,777 | 18.00 | 20,029,986 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oncology Impact Private Investment Fund 2, L.p. (Officer of Aktis Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.